Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Physicians on the Jewish Common Hospital are hailing new surgical procedures they consider will enhance look after prostate most cancers sufferers. Hospital officers...
WEDNESDAY, July 17, 2024 (HealthDay Information) -- Ophthalmologic manifestations of acute leukemia are heterogeneous and detectable at preliminary presentation or relapse, in line...
